Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Landscape of Mutations in Relapsed Acute Myeloid Leukemia

Samuli Eldfors, MSc, Mika Kontro, MD, Kimmo Porkka, MD PhD, Olli Kallioniemi, MD PhD, Caroline Heckman, PhD

Blood (2014) 124 (21): 2367.

https://doi.org/10.1182/blood.V124.21.2367.2367

Published: 2014

Journal Articles

Primary T-Prolymphocytic Leukemia (T-PLL) Cells Are Sensitive To BCL-2 and HDAC Inhibitors: Results From High-Throughput Ex Vivo Drug Testing

Emma I Andersson, MSc, Tea Pemovska, MSc, Samuli Eldfors, MSc, Anneli Lauhio, MD, Paavo Pietarinen, MSc, Edgar Faber, MD, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD, Caroline Heckman, PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD

Blood (2013) 122 (21): 3828.

https://doi.org/10.1182/blood.V122.21.3828.3828

Published: 2013

Journal Articles

Novel Activating STAT5B Mutations As Drivers Of T-ALL

Mika Kontro, MD, Heikki Kuusanmäki, MSc, Samuli Eldfors, MSc, Tea Pemovska, MSc, Hanna L M Rajala, MD, Henrik Edgren, PhD, Pekka Ellonen, MSc, Sonja Lagström, MSc, Tuija Lundán, PhD, Olli Kallioniemi, MD, PhD, Satu Mustjoki, MD, PhD, Kimmo Porkka, MD, PhD, Caroline Heckman, PhD

Blood (2013) 122 (21): 3863.

https://doi.org/10.1182/blood.V122.21.3863.3863

Published: 2013

Journal Articles

Somatic PTPRT and ANGPT2 Mutations in Large Granulocyte Leukemia

Emma I Andersson, MSc, Samuli Eldfors, MSc, Hanna L M Koskela, MD, Pekka Ellonen, MSc, Thomas Olson, BSc, Andres Jerez, MD, PhD, Michael J. Clemente, Olli Kallioniemi, MD, PhD, Kimmo Porkka, MD, PhD, Thomas P. Loughran, Jr., M.D., Jaroslaw P. Maciejewski, MD, PhD, Caroline Heckman, PhD, Satu Mustjoki, MD, PhD

Blood (2012) 120 (21): 1302.

https://doi.org/10.1182/blood.V120.21.1302.1302

Published: 2012

Journal Articles

Recurrent Missense Mutations in the STAT3 Gene in LGL Leukemia Provide Insights to Pathogenetic Mechanisms and Suggest Potential Diagnostic and Therapeutic Applications

Hanna Koskela, MD, Samuli Eldfors, MSc, Henrikki Almusa, MSc, Emma Andersson, Pekka Ellonen, BSc, Henrik Edgren, MSc, Pirjo Koistinen, MD, PhD, Taru Kuittinen, MD, PhD, Kati Penttinen, Jonathan Knowles, PhD, Janna Saarela, MD, PhD, Olli Kallioniemi, MD, PhD, Krister Wennerberg, PhD, Kimmo Porkka, MD, PhD, Caroline Heckman, PhD, Satu Mustjoki, MD, PhD

Blood (2011) 118 (21): 936.

https://doi.org/10.1182/blood.V118.21.936.936

Published: 2011

Journal Articles

Development of a Cancer Pharmacopeia-Wide Ex-Vivo Drug Sensitivity and Resistance Testing (DSRT) Platform: Identification of MEK and mTOR As Patient-Specific Molecular Drivers of Adult AML and Potent Therapeutic Combinations with Dasatinib

Mika Kontro, MD, Caroline Heckman, PhD, Evgeny Kulesskiy, MSc, Tea Pemovska, MSc, Maxim Bespalov, PhD, Samuli Eldfors, MSc, Elonen Erkki, MD, PhD, Riikka Karjalainen, MSc, Jonathan Knowles, PhD, Disha Malani, MSc, Muntasir Mamun Majumder, MSc, John Patrick Mpindi, MSc, PhD, Astrid Murumägi, PhD, Satu Mustjoki, MD, PhD, Laura Turunen, MSc, Maija Wolf, PhD, Kimmo Porkka, MD, PhD, Krister Wennerberg, PhD, Olli Kallioniemi, MD, PhD

Blood (2011) 118 (21): 2487.

https://doi.org/10.1182/blood.V118.21.2487.2487

Published: 2011

Journal Articles

Phosphoprotein Profiling Predicts Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients

Sari E Jalkanen, MSc, Anna-Maria Lahesmaa-Korpinen, MSc, Caroline Heckman, PhD, Ville Rantanen, MSc, Kimmo Porkka, MD, PhD, Sampsa Hautaniemi, PhD, Satu Mustjoki, MD, PhD

Blood (2011) 118 (21): 4427.

https://doi.org/10.1182/blood.V118.21.4427.4427

Published: 2011

NARROW

Landscape of Mutations in Relapsed Acute Myeloid Leukemia

Primary T-Prolymphocytic Leukemia (T-PLL) Cells Are Sensitive To BCL-2 and HDAC Inhibitors: Results From High-Throughput Ex Vivo Drug Testing

Novel Activating STAT5B Mutations As Drivers Of T-ALL

Somatic PTPRT and ANGPT2 Mutations in Large Granulocyte Leukemia

Recurrent Missense Mutations in the STAT3 Gene in LGL Leukemia Provide Insights to Pathogenetic Mechanisms and Suggest Potential Diagnostic and Therapeutic Applications

Development of a Cancer Pharmacopeia-Wide Ex-Vivo Drug Sensitivity and Resistance Testing (DSRT) Platform: Identification of MEK and mTOR As Patient-Specific Molecular Drivers of Adult AML and Potent Therapeutic Combinations with Dasatinib

Phosphoprotein Profiling Predicts Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Landscape of Mutations in Relapsed Acute Myeloid Leukemia

Primary T-Prolymphocytic Leukemia (T-PLL) Cells Are Sensitive To BCL-2 and HDAC Inhibitors: Results From High-Throughput Ex Vivo Drug Testing

Novel Activating STAT5B Mutations As Drivers Of T-ALL

Somatic PTPRT and ANGPT2 Mutations in Large Granulocyte Leukemia

Recurrent Missense Mutations in the STAT3 Gene in LGL Leukemia Provide Insights to Pathogenetic Mechanisms and Suggest Potential Diagnostic and Therapeutic Applications

Development of a Cancer Pharmacopeia-Wide Ex-Vivo Drug Sensitivity and Resistance Testing (DSRT) Platform: Identification of MEK and mTOR As Patient-Specific Molecular Drivers of Adult AML and Potent Therapeutic Combinations with Dasatinib

Phosphoprotein Profiling Predicts Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only